Percheron Therapeutics Limited Share Price BOERSE MUENCHEN
Equities
AWY0
AU0000317281
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0546 EUR | +1.49% | +4.67% | +56.40% |
17/06 | Percheron Therapeutics Appoints CFO | MT |
03/06 | Percheron Therapeutics Names Chief Medical Advisor | MT |
Sales 2024 * | 3.6M 2.4M 2.23M 200M | Sales 2025 * | 5.3M 3.53M 3.28M 294M | Capitalization | 75.73M 50.41M 46.93M 4.2B |
---|---|---|---|---|---|
Net income 2024 * | -13M -8.65M -8.06M -721M | Net income 2025 * | -31M -20.63M -19.21M -1.72B | EV / Sales 2024 * | 18.6 x |
Net cash position 2024 * | 8.92M 5.94M 5.53M 495M | Net cash position 2025 * | 17.43M 11.6M 10.8M 966M | EV / Sales 2025 * | 11 x |
P/E ratio 2024 * |
-5.36
x | P/E ratio 2025 * |
-2.13
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.66% |
1 week | +4.67% | ||
Current month | +3.26% | ||
1 month | +17.72% | ||
3 months | -15.01% | ||
6 months | +71.34% | ||
Current year | +56.40% |
Managers | Title | Age | Since |
---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 08/23/08 |
Anthony Filippis
COO | Chief Operating Officer | - | 01/22/01 |
Andrew McKenzie
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ben Price
BRD | Director/Board Member | 68 | 04/21/04 |
James Garner
CEO | Chief Executive Officer | - | 08/23/08 |
Chairman | - | 22/21/22 |
Date | Price | Change |
---|---|---|
19/24/19 | 0.0546 | +1.49% |
17/24/17 | 0.0538 | +1.70% |
14/24/14 | 0.0529 | +2.92% |
13/24/13 | 0.0514 | 0.00% |
12/24/12 | 0.0514 | 0.00% |
Real-time BOERSE MUENCHEN, June 19, 2024 at 01:13 am IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.84% | 122B | |
+18.31% | 113B | |
+3.61% | 22.66B | |
-18.26% | 21.34B | |
-41.55% | 16.92B | |
-14.23% | 16.68B | |
-16.03% | 16.61B | |
-0.68% | 13.62B | |
+21.87% | 11.04B |
- Stock Market
- Equities
- PER Stock
- AWY0 Stock